The Southeast Asian
Journal of Case Report and Review
Service by

Home Journal Issues Guide for Authors Editorial Board About Journal Aims & Scope


Case Report Open Access


Rituximab Induced Thrombocytopenia: A Case Report

Dr.Sneha N Agarwal, Dr. Ajita Pillai, Dr. Bharti N Karelia.

Abstract
Rituximab, an anti-CD20 monoclonal antibody, is a generally safe and well-tolerated drug. In recent years, Rituximab has been widely used off-label as the second line treatment in both adults and children with Idiopathic thrombocytopenic purpura (ITP) refractory to first line treatment. Episodes of Rituximab-induced neutropenia have been reported in some patients, but severe acute thrombocytopenia is very unusual. A 43-year-old woman, with diagnosis of Idiopathic thrombocytopenic purpura refractory to first line therapy was treated with Inj. Rituximab 500mg/week for four doses. After the 3rd dose, her platelet count had fallen from pre-infusion level of 1, 17, 000/mm3 to 79,000/mm3 but no signs of hemorrhage. So, it is diagnosed as Rituximab induced thrombocytopenia and clinician decided to delay the 4th dose by a week. After 15 days of 3rd dose, platelet count increased to 88,000/mm3. Then the 4th dose was given. Over the course of time, platelet count showed further increase. Few cases of acute thrombocytopenia with Rituximab infusion have been reported. In our case fall in platelet count was not sudden but was gradual occurring after 1st week. Rituximab-induced thrombocytopenia is likely under diagnosed because most patients do not have blood counts performed the day after treatment. Rituximab should therefore be used with caution; routine blood count should be done frequently to document this potential adverse effect. This case is reported to emphasize a rare and unusual adverse reaction to Rituximab. Early recognition of Rituximab induced thrombocytopenia is critical to prevent serious sequelae.

Key words: Rituximab, Idiopathic thrombocytopenic Purpura, Thrombocytopenia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Dr.Sneha N Agarwal
Articles by Dr. Ajita Pillai
Articles by Dr. Bharti N Karelia
on Google
on Google Scholar
Article Statistics
 Viewed: 1646
Downloaded: 384
Cited: 0


How to Cite this Article
Pubmed Style

Agarwal DN, Pillai DA, Karelia DBN. Rituximab Induced Thrombocytopenia: A Case Report . SEAJCRR. 2013; 2(4): 229-232.


Web Style

Agarwal DN, Pillai DA, Karelia DBN. Rituximab Induced Thrombocytopenia: A Case Report . http://www.seajcrr.com//?mno=41063 [Access: December 12, 2017].


AMA (American Medical Association) Style

Agarwal DN, Pillai DA, Karelia DBN. Rituximab Induced Thrombocytopenia: A Case Report . SEAJCRR. 2013; 2(4): 229-232.



Vancouver/ICMJE Style

Agarwal DN, Pillai DA, Karelia DBN. Rituximab Induced Thrombocytopenia: A Case Report . SEAJCRR. (2013), [cited December 12, 2017]; 2(4): 229-232.



Harvard Style

Agarwal, D. N., Pillai, D. A. & Karelia, D. B. N. (2013) Rituximab Induced Thrombocytopenia: A Case Report . SEAJCRR, 2 (4), 229-232.



Turabian Style

Agarwal, Dr.Sneha N, Dr. Ajita Pillai, and Dr. Bharti N Karelia. 2013. Rituximab Induced Thrombocytopenia: A Case Report . The Southeast Asian Journal of Case Report and Review, 2 (4), 229-232.



Chicago Style

Agarwal, Dr.Sneha N, Dr. Ajita Pillai, and Dr. Bharti N Karelia. "Rituximab Induced Thrombocytopenia: A Case Report ." The Southeast Asian Journal of Case Report and Review 2 (2013), 229-232.



MLA (The Modern Language Association) Style

Agarwal, Dr.Sneha N, Dr. Ajita Pillai, and Dr. Bharti N Karelia. "Rituximab Induced Thrombocytopenia: A Case Report ." The Southeast Asian Journal of Case Report and Review 2.4 (2013), 229-232. Print.



APA (American Psychological Association) Style

Agarwal, D. N., Pillai, D. A. & Karelia, D. B. N. (2013) Rituximab Induced Thrombocytopenia: A Case Report . The Southeast Asian Journal of Case Report and Review, 2 (4), 229-232.



AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

Index Scholar, 

Index Copernicus, 

journalindex.net 

Global impact Factor 



www.AcademicKeys.com
nick@AcademicKeys.com

Journal Impact factor for 2012 (0.421),

Now increasing in 2013 is 0.531 

Open Academic Journals Index

 

IMSEAR Institutional Repository

http://imsear.hellis.org/handle/123456789/149642

 



The articles in The Southeast Asian Journal of Case Report and Review are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.